Unseen Upside S5:EP2 Drug Affordability: The High Cost of Healing

Published on October 22, 2024

Prescription drug prices in the United States are 2.78 times higher than in other developed countries, but why?

In this podcast episode, we untangle the barriers surrounding drug affordability and find out why accessing life-saving medications is costly to so many. Joined by experts, advocates, and one Cystic Fibrosis patient relying on expensive medication to live, we examine the complex factors contributing to the high costs of drugs, from research and development to pricing strategies and supply chain dynamics. We also investigate potential solutions to improve access and affordability without compromising on drug innovation.

Guests include:

  • Peter Kolchinsky, Founder and Managing Partner at RA Capital
  • Gunnar Esiason, Head of Patient Engagement at RAVen (RA Ventures)
  • Dean Dimizas, Partner in the Private Client Practice at Cambridge Associates

 

Listen to the episode here.

Other news

Unseen Upside S5:EP1 Investing in Affordable Homes for Healthier Communities

October 17, 2024
Join us as we head to the Bronx to examine the critical intersection of housing and health and the innovative solutions that are aiming to address the affordable housing crisis in major cities like New York and LA.Through conversations with non-profit leaders and impact investors, we dive into how affordable housing impacts public health and health equity, highlighting the investment strategies an

Will Japanese Equities Outperform Global Equities in US Dollars?

October 29, 2024
No, we do not expect Japanese mid-/large-cap equities to outperform their global peers despite some supportive factors, such as Tokyo Stock Exchange (TSE) reforms and inflows from security investment schemes. Japanese equities tend to underperform in global activity slowdowns and contractions, and current valuations do not offer sufficient compensation to bear that risk, given our macro views. In